Gryrotonic Training in Behcet-diseased Elders With Breast Cancer
Breast Cancer · Behcet Disease
De qué trata este estudio
El registro indica que este estudio recluta participantes. La disponibilidad puede variar por centro.
- Tipo de estudio
- De intervención
- Fase
- No aplica
- Rango de edad
- 65 años - 75 años
- Sexo admitido
- Femenino
- Voluntarios sanos
- No aceptados
- Participantes
- 40 Estimado
Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.
Las explicaciones y la navegación están en español. Los textos proporcionados por el registro, incluidos títulos, resúmenes y criterios, se conservan en su idioma original. Puedes pedir orientación en español a WCR.
Acerca de la investigación
gryrotonic training may be a good exercise modality in Behcet-diseased elders with breast cancer
Leer la descripción completa
forty Behcet-diseased elders with breast cancer will randomy divide into group I (receive gyrotonic exercise three session weekly for 12 week) or group II (wait list)
¿Quién podría participar?
La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.
Inclusion Criteria:
- beast cancer survivors
- behcet diseas patients
Exclusion Criteria:
- cardiac or repiratory or renal failure patients
Tratamiento, grupos y participación
El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.
- Asignación
- Asignación al azar
- Enmascaramiento
- Enmascaramiento simple
group number 1
twenty Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will 45 min
Behavioral: exercise
group number 2
twenty Behcet-diseased elders who survivied from breast cancer will be wait list for 12 weeks
exercise BEHAVIORAL
twnety Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will last for 45 min
Qué evalúan los investigadores
Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.
Medidas principales
Short Physical Performance Battery
Plazo: it will be measured after 12 weeks
the total score will be calcualted
Medidas secundarias
Dual task gait speed
Plazo: It will be measured after 12 weeks
this task assess gait speed
Four-square step test
Plazo: It will be measured after 12 weeks
it is fucntional balnce test
grip strenghts
Plazo: It will be measured after 12 weeks
it is a measure of grip strenghths in dominant hand
time up- and go testing
Plazo: It will be measured after 12 weeks
it is a measure of fall risk
sit-to-stand 30-second testing
Plazo: It will be measured after 12 weeks
asess number of repteations of sit-to-staning in 30 seconds
six minute walking testingg
Plazo: It will be measured after 12 weeks
distance covered by subject in six minutes wil be assessed
10-meters walking testing
Plazo: It will be measured after 12 weeks
time covered for walking for ten meter will be assessed
trunk-flexor McGill core endurance test
Plazo: It will be measured after 12 weeks
this test will assess endurance of trunk flexors
trunk-extensor McGill core endurance test
Plazo: It will be measured after 12 weeks
this test will assess endurance of trunk extensors
right-lateral-trunk-bending McGill core endurance test
Plazo: It will be measured after 12 weeks
this test will assess endurance of right lateral trunk bendors
left-lateral-trunk-bending McGill core endurance test
Plazo: It will be measured after 12 weeks
this test will assess endurance of left lateral trunk bendors
arm flexion in thrity seconds
Plazo: It will be measured after 12 weeks
it will assess numbers (repeations) of arm flexion in thirty second
maximal nubmer of push up
Plazo: It will be measured after 12 weeks
this will assess maximal number of performed psh ups in speciifc time
behcet disease quality of life
Plazo: It will be measured after 12 weeks
questioanire that will assess life quality in behcet disease (total score will be estiamted)
total score of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it is a questioaire asess quality of life
physical fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it is a questioaire asess physical fucntion related quality of life
role fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it is a questioaire asess role fucntion related quality of life
emotional fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it is a questioaire asess emotional fucntion related quality of life
cognitive fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it is a questioaire asess cognitive fucntion related quality of life
social fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it is a questioaire asess social fucntion related quality of life
fatigue fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it is a questioaire asess fatigue
nausea-vomiting subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it is a questioaire asess nausea-vomiting
pain subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it will assess pain
dyspnea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it will assess dyspnea
insomnia subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it will assess insomnia
appetite-loss subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it will assess appetite loss
constipation subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it will assess constipation
diarrhea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it will assess diarrhea
financial difficulties subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Plazo: It will be measured after 12 weeks
it will assess financial difficulties
Revisa las tablas completas y sus limitaciones en el registro oficial.
Abrir resultados oficiales ↗Centros de investigación (1)
El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.
1 centros
Cairo UniversityGiza, Dokki, EgyptReclutando
Equipo y fechas
- Patrocinador principal
- Cairo University
- Inicio del estudio
- 30 nov 2026 Estimado
- Finalización primaria
- 30 may 2027 Estimado
- Finalización del estudio
- 30 may 2027 Estimado
- Primera publicación
- 10 nov 2026 Real
- Última actualización
- 10 nov 2026 Real
Contactos oficiales del estudio
Título oficial del estudio
Gryrotonic Training in Behcet-diseased Elders With Breast Cancer
Consulta a Wellness Clinical Research
Tu mensaje va a WCR, incluso si otra organización realiza este estudio. WCR puede orientarte, pero podría no realizar este estudio, tener acceso a su equipo ni poder inscribirte.
Fuente: API v2 de ClinicalTrials.gov. Patrocinadores e investigadores envían la información. La NLM no aprueba la seguridad ni la ciencia de todos los estudios registrados. Aviso del registro.
Consultado: 12 nov 2026 · Última actualización del registro: 10 nov 2026